<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>1028-4818</journal-id>
<journal-title><![CDATA[Multimed]]></journal-title>
<abbrev-journal-title><![CDATA[Multimed]]></abbrev-journal-title>
<issn>1028-4818</issn>
<publisher>
<publisher-name><![CDATA[Centro Provincial de Información de Ciencias Médicas]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S1028-48182021000200013</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Tumor de estroma gastrointestinal: a propósito de un caso y revisión de la literatura]]></article-title>
<article-title xml:lang="en"><![CDATA[Gastrointestinal stromal tumor: report of a case and review of the literature]]></article-title>
<article-title xml:lang="pt"><![CDATA[Tumor estromal gastrointestinal: relato de um caso e revisão da literatura]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Turruelles Ramírez]]></surname>
<given-names><![CDATA[Alberto]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Sánchez Borges]]></surname>
<given-names><![CDATA[Eduardo C.]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Ricardo Martínez]]></surname>
<given-names><![CDATA[Daimi]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Universidad de Ciencias Médicas de Granma Hospital General Docente Universitario Carlos Manuel de Céspedes ]]></institution>
<addr-line><![CDATA[Bayamo Granma]]></addr-line>
<country>Cuba</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>04</month>
<year>2021</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>04</month>
<year>2021</year>
</pub-date>
<volume>25</volume>
<numero>2</numero>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_arttext&amp;pid=S1028-48182021000200013&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_abstract&amp;pid=S1028-48182021000200013&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_pdf&amp;pid=S1028-48182021000200013&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[RESUMEN  Introducción:  los tumores del estroma gastrointestinal (GIST), son las neoplasias de origen mesenquimático más frecuentes del tracto digestivo, sin embargo, representan menos del 1% de todos estos tumores. Actualmente se denominan GIST a los tumores mesenquimales CD117 positivos, fusiformes o epitelioides, primarios del tracto gastrointestinal, epiplón, mesenterio y retroperitoneo.  Presentación de caso:  presentamos un paciente de 60 años de edad que fue ingresado en el servicio de Medicina Interna por anemia crónica y dispepsia. Al examen físico se constata en la palpación de abdomen un tumor en hipocondrio derecho y epigastrio, no mesurable, fijo, doloroso. Se realizan complementarios como ecografía abdominal, esófago gastroduedenoscopia, TAC abdominal y laparoscopia demostrándose la presencia de un tumor de la curvatura mayor gástrica de aproximadamente 20 cm con crecimiento exofitico. Se interviene quirúrgicamente, realizándose gastrectomía total, espelenctomia y esofagoyeyunostomia. Los resultados definitivos de anatomía patológica informan: tumor de pared gástrica, fusocelular del estroma gastrointestinal, de bajo potencial. Tamaño del tumor 25cm. Índice Mitótico de 1 mitosis por 50 HPF con Inmunohistoquímica positiva para CD117, CD34, cumplió tratamiento quimioterapia y presenta una evolución favorable.  Discusión: los GIST son tumores cuya presencia de síntomas dependerá del tamaño y localización del tumor y puede variar desde formas asintomáticas a casos que se presenten como una emergencia quirúrgica por perforación gástrica o sangramiento digestivo.  Conclusiones: el paciente fue intervenido quirúrgicamente encontrándose un tumor fusocelular del estroma gastrointestinal (GIST) de pared gástrica, de bajo potencial de malignidad, comportamiento agresivo.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[ABSTRACT  Introduction:  the Gastrointestinal Stroma Tumors (GIST), the neoplasia from which those stem are those of highest mesenquimatic frequency of the digestive tract, However, it represents less than 1 % of all these tumors. At present, mesenquimales name the tumors GIST CD117 positive, fusiform or epithelioid, primary of the tract gastrointestinal, epiplón, mesentery and retro-peritoneum.  Case presentation:  we introduced a 60-year-old patient that went through admittance in the Internal Medicine service due to chronic anemia and dyspepsia. To the physical examination through palpationof the abdomen, a tumor in straight hypochondrium and epigastrium is verified, notmeasurable, It is fixed, painful. Complementary tests are also performed, like abdominal echography, esophagus gastroduedenoscopy abdominal CAT and laparoscopy, showing the presence of a tumor of the bigger gastric curvature of approximately 20 cm with exofitic growth. Surgery is performed, coming true total gastrectomy, splenectomy and esofagoyeyunostomy, which have proven to be definite of morbid anatomy, as the inform discloses: Tumor of gastricwall, gastrointestinal fusocellular stroma, of potential bass. Size of the tumor 25cm. Meiotic index of 1 mitosis for 50 HPF with positive Inmunohistochemical for CD117, CD34, treatment fulfilled chemotherapy and it presents a favorable evolution.  Discussion: the GIST symptoms are depended of the tumor size and localization. They had some types of clinical presentation such as gastric perforation or haemorrage.  Conclusion: in the OR we found a gastrointestinal fusocelullar tumor, at the gastric wall. With very aggressive behavior.]]></p></abstract>
<abstract abstract-type="short" xml:lang="pt"><p><![CDATA[RESUMO  Introdução:  os tumores estromais gastrointestinais (GIST) são as neoplasias mais frequentes de origem mesenquimal do trato digestivo, porém representam menos de 1% de todos esses tumores. Atualmente, os GISTs são positivos para CD117, fusiformes ou epitelióides, tumores mesenquimais primários do trato gastrointestinal, omento, mesentério e retroperitônio.  Apresentação do caso:  apresentamos um paciente de 60 anos que deu entrada no serviço de Clínica Médica por anemia crônica e dispepsia. O exame físico revelou tumor doloroso, fixo e não mensurável em quadrante superior direito e epigástrio à palpação de abdome. Exames complementares como ultrassonografia abdominal, gastroduedenoscopia de esôfago, tomografia computadorizada de abdome e laparoscopia são realizados, demonstrando a presença de tumor da grande curvatura gástrica de aproximadamente 20 cm com crescimento exofítico. Foi realizada intervenção cirúrgica, realizando gastrectomia total, espelenctomia e esofagojejunostomia. Os resultados definitivo do laudo anatomopatológico: tumor da parede gástrica, fusocelular do estroma gastrointestinal, de baixo potencial. Tamanho do tumor: 25cm. Índice mitótico de 1 mitose por 50 HPF com imunoistoquímica positiva para CD117, CD34, foi submetido a tratamento quimioterápico e apresenta evolução favorável.  Discussão:  GISTs são tumores cuja presença de sintomas dependerá do tamanho e localização do tumor e podem variar desde formas assintomáticas até casos que se apresentam como emergência cirúrgica por perfuração gástrica ou sangramento digestivo.  Conclusões:  a paciente foi operada e encontrou tumor de células fusiformes do estroma gastrointestinal (GIST) da parede gástrica, com baixo potencial de malignidade e comportamento agressivo.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[Tumores del estroma gastrointestinal]]></kwd>
<kwd lng="en"><![CDATA[Stroma gastrointestinal tumors]]></kwd>
<kwd lng="pt"><![CDATA[Tumores estromais gastrointestinais]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Soriano Lorenzo]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Lima Pérez]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Soriano García]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Zaldívar Blanco]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Fleites Clavo]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Tumor del estroma gastrointestinal]]></article-title>
<source><![CDATA[An Fac med]]></source>
<year>2019</year>
<volume>80</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>214-21</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sahin]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Ekinci]]></surname>
<given-names><![CDATA[O]]></given-names>
</name>
<name>
<surname><![CDATA[Seckin]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The Diagnosis and prognostic utility of DOG1 expression on gastrointestinal stromal tumors]]></article-title>
<source><![CDATA[Turk Patoloji Dreg]]></source>
<year>2017</year>
<volume>33</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>1-8</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Haliberto Armenteros]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Presentación de un paciente con tumor estromal gastrointestinal de localización gástrica]]></article-title>
<source><![CDATA[CCM]]></source>
<year>2014</year>
<volume>18</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>785-92</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Von Mehren]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Joensuu]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Gastrointestinal stromal tumors]]></article-title>
<source><![CDATA[J Clin Oncol]]></source>
<year>2018</year>
<volume>36</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>136-43</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Joensuu]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Wadermann]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Sihto]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Eriksson]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Sundby Hall]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Reichardt]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Effecto of KIT and PDGFRA mutations on survival in patients with gastrointestinal stromal tumors trated with adyuvant imatin9ib: an exploratory analysis of a randomized clinical tried]]></article-title>
<source><![CDATA[JAMA Oncol]]></source>
<year>2017</year>
<volume>3</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>602-9</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gopie]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Mei]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Faber]]></surname>
<given-names><![CDATA[AC]]></given-names>
</name>
<name>
<surname><![CDATA[Grossman]]></surname>
<given-names><![CDATA[SR]]></given-names>
</name>
<name>
<surname><![CDATA[Smith]]></surname>
<given-names><![CDATA[ST]]></given-names>
</name>
<name>
<surname><![CDATA[Boikos]]></surname>
<given-names><![CDATA[SA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Calssification of gastrointestinal stromal tumor síndromes]]></article-title>
<source><![CDATA[Endocr Relat Cáncer]]></source>
<year>2018</year>
<volume>25</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>R49-58</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Casali]]></surname>
<given-names><![CDATA[PG]]></given-names>
</name>
<name>
<surname><![CDATA[Zalcberg]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Le Cesne]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Reichardt]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Blay]]></surname>
<given-names><![CDATA[JY]]></given-names>
</name>
<name>
<surname><![CDATA[Lindner]]></surname>
<given-names><![CDATA[LH]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Ten year progression-free and overall survival in patients with unresectable or metastatic GI stromat tumors: long term analysis of the European Organization for Research and Treatment of cáncer, Italian Sarcoma Group and Australasian Gastrointestinal Trials Groups Inter-group phase III randomized trial on imatininib at two dose levels]]></article-title>
<source><![CDATA[J Clin Oncol]]></source>
<year>2017</year>
<volume>35</volume>
<numero>15</numero>
<issue>15</issue>
<page-range>1713-20</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Verdecía Cañizares]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Villamil Martínez]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Monteros Reyes]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Pineda Frenández]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Tumor estromal gastrointestinal]]></article-title>
<source><![CDATA[Rev Cubana Pediatr]]></source>
<year>2017</year>
<volume>89</volume>
<numero>1</numero>
<issue>1</issue>
</nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sánchez Hidalgo]]></surname>
<given-names><![CDATA[JM]]></given-names>
</name>
<name>
<surname><![CDATA[Duran Martínez]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Molero Payan]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Rufian Peña]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Arjona Sánchez]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Casado Adam]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Gatsrointestinal stromal tumors: a multidisciplinary challenge]]></article-title>
<source><![CDATA[World J Gastroenterol]]></source>
<year>2018</year>
<volume>24</volume>
<numero>18</numero>
<issue>18</issue>
<page-range>1925-41</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lin]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Du]]></surname>
<given-names><![CDATA[W]]></given-names>
</name>
<name>
<surname><![CDATA[Idowu]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Mehren]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Boikos]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Advanced and challenges on managment of gastrointestinal stromal tumors]]></article-title>
<source><![CDATA[Front Oncol]]></source>
<year>2018</year>
<volume>8</volume>
</nlm-citation>
</ref>
</ref-list>
</back>
</article>
